Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

Clinical trial NCT01292460 · COMPLETED

Trial details

NCT number: NCT01292460
Sponsor: Santen Oy
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension Open-angle Glaucoma

Start date: 2011-02-01
Primary completion: 2012-09-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.